6 Brevetti
 Distribuzione geografica
Continente #
NA - Nord America 6.783
EU - Europa 5.635
AS - Asia 4.223
SA - Sud America 385
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 17.082
Nazione #
US - Stati Uniti d'America 6.720
IT - Italia 1.576
CN - Cina 1.393
SE - Svezia 1.136
SG - Singapore 1.023
IE - Irlanda 760
KR - Corea 684
RU - Federazione Russa 569
TR - Turchia 520
DE - Germania 470
UA - Ucraina 380
BR - Brasile 349
GB - Regno Unito 286
HK - Hong Kong 249
VN - Vietnam 182
FI - Finlandia 143
CH - Svizzera 114
AT - Austria 47
IN - India 39
FR - Francia 36
CA - Canada 35
BD - Bangladesh 26
AE - Emirati Arabi Uniti 21
EU - Europa 21
PL - Polonia 21
NL - Olanda 20
AL - Albania 19
MX - Messico 19
ES - Italia 18
BE - Belgio 17
ZA - Sudafrica 16
AR - Argentina 13
IQ - Iraq 13
PK - Pakistan 13
JP - Giappone 12
LT - Lituania 8
EC - Ecuador 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
ID - Indonesia 5
MA - Marocco 5
PE - Perù 5
VE - Venezuela 5
IL - Israele 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
JO - Giordania 3
KG - Kirghizistan 3
MY - Malesia 3
CO - Colombia 2
HU - Ungheria 2
IR - Iran 2
KZ - Kazakistan 2
LK - Sri Lanka 2
ME - Montenegro 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
CL - Cile 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 17.082
Città #
Pisa 981
Jacksonville 864
Dublin 760
Chandler 751
Dallas 738
Seoul 683
Ashburn 534
Boardman 468
Izmir 404
Singapore 390
Wilmington 365
Ann Arbor 328
Beijing 296
Hefei 253
Hong Kong 244
Düsseldorf 185
Boston 179
Millbury 176
Moscow 162
Dong Ket 150
Kent 117
San Mateo 116
Mestre 108
Istanbul 106
Bern 92
Los Angeles 91
Seattle 87
Woodbridge 85
Dearborn 79
Bremen 76
New York 72
The Dalles 72
Lawrence 71
Ogden 66
Scuola 65
Milan 61
Princeton 55
Chicago 45
Guangzhou 43
Saint Petersburg 43
Vienna 41
San Giuliano Terme 39
Munich 38
Buffalo 32
Santa Clara 32
Shanghai 30
São Paulo 29
Brescia 27
Rome 24
Council Bluffs 23
Orem 23
North Bergen 22
Nanjing 21
Padova 21
Wuhan 21
Brooklyn 20
Warsaw 20
Helsinki 18
Kunming 18
Zurich 18
Washington 17
Brussels 16
Chennai 15
Montreal 15
Andover 14
Jiaxing 14
Norwalk 14
Jinan 13
London 13
San Jose 13
Toronto 13
Turku 13
Bientina 12
Florence 12
Ho Chi Minh City 12
Johannesburg 12
Manchester 12
Poplar 12
Tokyo 12
Yiwu 12
Cambridge 11
Fairfield 11
Frankfurt am Main 11
Stockholm 11
Atlanta 10
Denver 10
Houston 10
Mexico City 10
Phoenix 10
Rio de Janeiro 10
San Francisco 10
Wuxi 10
Nuremberg 9
Changsha 8
Hangzhou 8
Nanchang 8
San Diego 8
Amsterdam 7
Ankara 7
Baghdad 7
Totale 11.430
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 279
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 271
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 271
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 258
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 255
Composti particolarmente catalizzatori di poliuretani 249
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 237
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 225
Method and device for measuring position and mass 223
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 218
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 217
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 210
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 208
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 199
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 194
Laser circolari a semiconduttore con reticoli per emissione verticale 194
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 191
Bucket brigade address decoding architecture for classical and quantum random access memories 187
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 183
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 179
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 178
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 165
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 163
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 160
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 160
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 156
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 156
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 155
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 154
Method for the humanization of antibodies and humanized antibodies thereby obtained 153
INTRACELLULAR ANTIBODIES 153
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 151
Method for the humanization of antibodies and humanized antibodies thereby obtained 151
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 150
Method for the potentiation of opioid analgesics effects on pain 149
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 149
Method for the humanization of antibodies and humanized antibodies thereby obtained. 145
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 145
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 142
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 140
Humanized anti-NGF antibodies 140
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 140
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 140
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 139
Selection of intracellular immunoglobulins 139
Method for the humanization of antibodies and humanized antibodies thereby obtained. 138
Method for the potentiation of opioid analgesics effects on pain 138
Intracellular selection 137
Method of identifying a consensus sequence for intracellular antibodies 137
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 136
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 136
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 136
Method for the humanization of antibodies and humanized antibodies thereby obtained 135
Intracellular selection 135
Novel analgesic treatment with prolonged effect 134
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 134
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 133
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 133
Humanized anti-NGF antibodies 133
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 133
Intracellular selection 132
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 132
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 132
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 131
Selection of intracellular immunoglobulins 130
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 129
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 129
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 129
null 129
Novel analgesic treatment with prolonged effect 129
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 129
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 127
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 126
Selection of intracellular immunoglobulins 126
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 126
Selection of intracellular immunoglobulins 126
INTRACELLULAR ANTIBODIES 126
Humanized anti-NGF antibodies 125
Method for the humanization of antibodies and humanized antibodies thereby obtained. 125
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 124
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 124
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 124
Selection of intracellular immunoglobulins 124
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 124
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 124
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 123
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 122
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 122
Non-human transgenic animals for the study of neurodegenerative syndromes 121
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 121
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 121
Method for the humanization of antibodies and humanized antibodies thereby obtained. 120
Method for the humanization of antibodies and humanized antibodies thereby obtained. 120
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 120
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 119
Method for the humanization of antibodies and humanized antibodies thereby obtained 119
Method for the potentiation of opioid analgesics effects on pain 118
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 118
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 118
Non Human Transgenic Animal as Model of Neurodegenerative Diseases and for the Early Diagnosis Thereof 117
Totale 15.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.119 0 0 0 0 0 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/20253.265 93 34 178 172 477 14 42 188 657 153 603 654
2025/20263.510 556 671 988 697 302 296 0 0 0 0 0 0
Totale 17.225